PHARMA MAR, S.A. (PHM.MC) Financials
PHM.MC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 341.2 million | 147.8 million |
| 2023-09-30 | 349.4 million | 143.2 million |
| 2023-06-30 | 358.7 million | 148.4 million |
| 2023-03-31 | 373.7 million | 156.8 million |
PHM.MC Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -8.4 million | 81000 |
| 2023-09-30 | -11.5 million | 82000 |
| 2023-06-30 | -16.9 million | 33000 |
| 2023-03-31 | 7.4 million | 101000 |
PHM.MC Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | -6.8 million |
| 2023-09-30 | 1.6 million |
| 2023-06-30 | 4.5 million |
| 2023-03-31 | -3.2 million |
PHM.MC Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 162.6 million | - | 3.8 million |
| 2023-09-30 | 174.4 million | - | 3.9 million |
| 2023-06-30 | 184.9 million | 29.1 million | 3.9 million |
| 2023-03-31 | 183.1 million | 28.5 million | 3.6 million |
PHM.MC Shares Outstanding
PHM.MC Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 5.7 million | 29.0 million | 5.0 million | 6.4 million |
| 2023-09-30 | 4.5 million | 23.7 million | 3.9 million | 5.0 million |
| 2023-06-30 | 5.5 million | 25.6 million | 5.6 million | 6.1 million |
| 2023-03-31 | 272000 | 21.1 million | 3.8 million | 6.0 million |
PHM.MC Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 40.5 million | 2.5 million |
| 2023-09-30 | 37.5 million | 3.1 million |
| 2023-06-30 | 46.2 million | 1.9 million |
| 2023-03-31 | 34.0 million | 2.1 million |
PHM.MC
Price: €28.96
Dividend Yield: 0.02%
Forward Dividend Yield: 1.82%
Payout Ratio: 67.50%
Dividend Per Share: 0.53 EUR
Earnings Per Share: 0.06 EUR
P/E Ratio: 44.77
Exchange: MCE
Sector: Healthcare
Industry: Biotechnology
Volume: 42769
Market Capitalization: 474.5 million
Average Dividend Frequency: 1
Years Paying Dividends: 4